BioTech Medics, Inc. (BMCS) has an overall financial health rating of B with a composite score of 0 out of 5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2026-02-23.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-02-23 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-02-13 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-02-09 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-02-06 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-02-05 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-02-04 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-02-03 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-02-02 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-01-29 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-01-28 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-01-27 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 | |
| 2026-01-26 | -/5 | -/5 | -/5 | -/5 | -/5 | -/5 |
